Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Axon Therapies

Request full access

Rebalancing Heart Failure | Axon Therapies

Santa Clara, United StatesFounded 2014Biotech & Life Sciences

About Axon Therapies

Axon Therapies operates in the medical device industry, focusing on innovative solutions for heart failure management. The company has developed a novel catheter system that leverages splanchnic ablation for volume management (SAVM). This system aims to treat a root cause of heart failure by selectively ablating a nerve pathway to restore volume balance, halt disease progression, and improve patient symptoms. Axon Therapies primarily serves healthcare providers and cardiologists who treat patients with heart failure. The company's business model involves the development and eventual commercialization of its investigational device, which is currently not approved for clinical use in any geography. Revenue will be generated through the sale of the Ablation System once it receives regulatory approval.

Source: Dealroom company data

At a glance

Status
Operational
Employees
10
Open positions
None listed
Dealroom signal
88.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Sep 2025 $32M $128M Deerfield · Earlybird Venture Capital · CD Capital · KOFA Healthcare Investments ↗
OtherOther financing Jul 2019 $0 — Deerfield · Action Potential Venture Capital —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Axon Therapies website traffic

Latest recorded traffic for Axon Therapies is 900 monthly website visits, down 25% over the last three months. Axon Therapies's team grew 11.1% over the past year.

Latest monthly visits900 3-month web change-25% 1-year team growth+11.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Axon Therapies in the Santa Clara ecosystem

Live from Dealroom

The Axon Therapies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Other known investors1 additional known investor

  • Action Potential Venture Capital
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Axon Therapies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Axon Therapies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.